We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FICO:NYSEFair Isaac Corporation Analysis

Data as of 2026-09-08 - not real-time

$933.30

Latest Price

8/10Risk

Risk Level: High

Executive Summary

At $933.30, Fair Isaac Corporation shows a bearish moving-average alignment, with shorter averages beneath longer ones. The last 30 days have lost 27.1%. Momentum indicators put RSI at 30.4 (approaching oversold) with MACD reading bearish. Price has been bracketed by support at $885.00 and resistance at $1,188.80.
The shares look undervalued, trading on 27.1 times earnings below a sector average of 33.3. Analyst price targets sit 56.8% above the current price. Revenue is growing at 25.7% on a 34.1% profit margin.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 89.3%, a beta of 0.43 and a maximum drawdown of 50.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 4/10 conviction over the longer horizon.

Top Market Events

Fair Isaac NYSE:FICO added Alogram's AI-powered fraud intelligence suite to the FICO Marketplace, expanding tools...What Happened? Shares of credit scoring and analytics company FICO NYSE:FICO fell 6.8% in the afternoon session after...For decades, Fair Isaac Corporation NYSE:FICO maintained a virtual monopoly over the US mortgage credit scoring market,...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1300.62
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 27.1 versus sector average of 33.3
  • Trading below the 200-day average of 1300.62

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 27.1 versus sector average of 33.3
  • Analyst targets imply +56.8% versus the current price
  • Profit margin of 34.1% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth25.70%
Profit Margin34.05%
P/E Ratio27.1
ROA39.98%
P/B Ratio-4.9
Op. Cash Flow$1.0B
Free Cash Flow$774.4M
Industry P/E33.3

Technical Analysis

TrendBearish
RSI30.4
Support$885.00
Resistance$1,188.80
MA 20$1,099.41
MA 50$1,162.59
MA 200$1,300.62
MACDBearish
VolumeIncreasing
Fear & Greed Index93.36

Valuation

Fair Value$987.71
Target Price$1,463.84
Upside/Downside56.85%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.43
Volatility89.27%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.